CLINICAL_TRIALS
trial_result
· 2013-09-05
Clinical Trial Update: Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis [Phase 3]
Summary
Phase 3 trial assessed fentanyl sublingual spray for opioid-tolerant cancer patients with or without oral mucositis; results have been posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: INSYS Therapeutics Inc | Conditions: Mucositis, Pain | Phase 3 | Status: COMPLETED | Results posted: 2013-09-05